The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of ...

Last week, readers were most interested in a story about Roche ramping up the commercialization of its sample self-collection devices for HPV.

M-Strip, the self-sampling kit for cervical cancer (HPV) and STI screening, provides a non-invasive alternative to ...

The company has also partnered with the Tata Institute for Genetics and Society (TIGS) to develop an Indigenous HPV PCR kit, ...

You can now test for HPV at home. HPV being a a leading cause cervical cancer. Addressing previous testing challenges such as ...

The self-collection solution, developed in collaboration with Roche and approved for use with Roche’s cobas® HPV test, is designed to provide a discreet and accessible screening option for women, ...

The new offering utilizes the FDA-cleared HPV self-collection solution from Roche (SIX: RO, ROG; OTCQX: RHHBY), approved for use with Roche's cobas® HPV test in May 2024.

The new offering utilizes the FDA-cleared HPV self-collection solution from Roche (SIX: RO, ROG; OTCQX: RHHBY), approved for use with Roche's cobas® HPV test in May 2024. Interested patients can opt ...

Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to ...

The self-collection solution, developed in collaboration with Roche and approved for use with Roche’s cobas® HPV test, is designed to provide a discreet and accessible screening option for ...

Key Features of Labcorp's HPV and STI Self-Collection Offerings: Self-collection for both HPV and STI testing can be ordered by a physician and completed in a healthcare setting or one of Labcorp's ...